3UCHIYAMA K, WAKATSUKI D, KAKINOKI B, et al. The long-lasting effect of TU-199, a noval H^+ , K^+ -ATPase inhibitior, on gastric acid secretion in dogs [ J]. J Pharm Pharmacol,1999,51 (4) :457 -464.
4SHIMKO S, NORIYUKI S, TOMOE I, et al. Pharmacokinetic Studies of, ( + )-5-methoxy-2-[ [ (4-methoxy-3,5-dimethylpyrid-2 -yl ) methyl ] sulfinyl ] - 1 H -imida zo [ 4,5 -b ] pyridine ( TU - 199 ),plasma concentration of TU- 199 in Rats and Dogs [J]. lyakukin Kenkyu,1999,30(3) :119 - 127.
5Kawakami Y, Akahane T, Yamaguchi M, et al. In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of helicobacter pylori[J]. J Antimicrobial Agents and Chemotherapy, 2000,2:458-461.
6Marcos F, Teixeira S, Luiz Ramos A, et al. Adsorptive voltammetric study of thorium-alizarin complexon complex at a carbon paste electrode[J]. Microchimica Acta, 2003,143(4):125-129.
7Nakai H, Shimamura Y, Kanazawa T, et al. Determination of a new H^+-K^+ ATPase inhibitor (E 3810) and its four metabolites in human plasma by high-performance liquid chromatography [J ]. J Chromatogr, 1994,660:211-220.
8Radi A, Abd El-Ghany N, Wahdan T. Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form[J]. Farrnaco, 2004,7 : 515-518.
